Evidence for endogenous interleukin-10 during nociception

Journal of Neuroimmunology

Volumn 139, Issue 1-2, 2003, Pages 145-149

  Tu, Huolin ^a   Juelich, Terry ^a   Smith, Eric M ^a   Tyring, Stephen K ^a   Rady, Peter L ^a   Hughes Jr , Thomas K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cytokine; DREAM; Interleukin 10; Nociception

Indexed keywords

INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 10;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; KNOCKOUT MOUSE; LATENT PERIOD; LICKING; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION;

EID: 0037870348     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00126-7     Document Type: Article

References (32)

1. Blalock J.E. Harnessing a neural-immune circuit to control inflammation and shock. J. Exp. Med. 195:2002;F25-F28.
2. Cheng H.Y., Pitcher G.M., Laviolette S.R., Whishaw I.Q., Tong K.I., Kockeritz L.K., Wada T., Joza N.A., Crackower M., Goncalves J., Sarosi I., Woodgett J.R., Oliveira-dos-Santos A.J., Ikura M., van der Kooy D., Salter M.W., Penninger J.M. DREAM is a critical transcriptional repressor for pain modulation. Cell. 108:2002;31-43.
3. Cunha J.M., Cunha F.Q., Poole S., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br. J. Pharmacol. 130:2000;1418-1424.
4. Fickenscher H., Hor S., Kupers H., Knappe A., Wittmann S., Sticht H. The interleukin-10 family of cytokines. Trends Immunol. 23:2002;89-96.
5. Gemma C., Smith E.M., Hughes T.K. Jr., Opp M.R. Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system. Cell. Mol. Neurobiol. 20:2000;419-431.
6. Hrda S., Votypka J., Kodym P., Flegr J. Transient nature of Toxoplasma gondii-induced behavioral changes in mice. J. Parasitol. 86:2000;657-663.
7. Hughes T.K., Cadet P., Rady P.L., Tyring S.K., Chin R., Smith E.M. Evidence for the production and action of interleukin-10 in pituitary cells. Cell. Mol. Neurobiol. 14:1994;59-69.
8. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature. 413:2001;203-210.
9. Kanaan S.A., Poole S., Saade N.E., Jabbur S., Safieh-Garabedian B. Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J. Neuroimmunol. 86:1998;142-150.
10. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
11. Laughlin T.M., Bethea J.R., Yezierski R.P., Wilcox G.L. Cytokine involvement in dynorphin-induced allodynia. Pain. 84:2000;159-167.
12. Liposits Z., Merchenthaler I., Wetsel W.C., Reid J.J., Mellon P.L., Weiner R.I., Negro-Vilar A. Morphological characterization of immortalized hypothalamic neurons synthesizing luteinizing hormone-releasing hormone. Endocrinology. 129:1991;1575-1583.
13. Mellon P.L., Windle J.J., Weiner R.I. Immortalization of neuroendocrine cells by targeted oncogenesis. Recent Prog. Horm. Res. 47:1991;69-93. (discussion 93-66).
14. Mellon P.L., Wetsel W.C., Windle J.J., Valenca M.M., Goldsmith P.C., Whyte D.B., Eraly S.A., Negro-Vilar A., Weiner R.I. Immortalized hypothalamic gonadotropin-releasing hormone neurons. Ciba Found. Symp. 168:1992;104-117. (discussion 117-126).
15. Miller L.J., Fischer K.A., Goralnick S.J., Litt M., Burleson J.A., Albertsen P., Kreutzer D.L. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J. Urol. 167:2002;753-756.
16. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:2001;131-138.
17. Opp M.R., Smith E.M., Hughes T.K. Jr. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J. Neuroimmunol. 60:1995;165-168.
18. Opp M.R., Rady P.L., Hughes T.K. Jr., Cadet P., Tyring S.K., Smith E.M. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats [published errata appear in Am. J. Physiol. 1996 Aug; 271(2 Pt 2):section R following table of contents and 1996 Dec; 271(6 Pt 3):section R following table of contents]. Am. J. Physiol. 270:1996;R963-R970.
19. Ozaki K., Leonard W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 277:2002;29355-29358.
20. Plunkett J.A., Yu C.G., Easton J.M., Bethea J.R., Yezierski R.P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 168:2001;144-154.
21. Rady P.L., Smith E.M., Cadet P., Opp M.R., Tyring S.K., Hughes T.K. Jr. Presence of interleukin-10 transcripts in human pituitary and hypothalamus. Cell. Mol. Neurobiol. 15:1995;289-296.
22. Ramer M.S., Murphy P.G., Richardson P.M., Bisby M.A. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain. 78:1998;115.
23. Sei Y., Vitkovic L., Yokoyama M.M. Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. Neuroimmunomodulation. 2:1995;121-133.
24. Smith E.M., Cadet P., Stefano G.B., Opp M.R., Hughes T.K. Jr. IL-10 as a mediator in the HPA axis and brain. J. Neuroimmunol. 100:1999;140-148.
25. Sommer C. Cytokines in neuropathic pain. Anaesthesist. 50:2001;416-426.
26. Stefano G.B., Prevot V., Beauvillain J.C., Hughes T.K. Interleukin-10 stimulation of corticotrophin releasing factor median eminence in rats: evidence for dependence upon nitric oxide production. Neurosci. Lett. 256:1998;167-170.
27. Stefano G.B., Kahoud J., Hughes T.K. Inhibition of microglial egress in excised ganglia by human interleukin 10: implications for its activity in invertebrates. Acta Biol. Hung. 50:1999;247-256.
28. Vitkovic L., Maeda S., Sternberg E. Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation. 9:2001;295-312.
29. Vogt B.A. Knocking out the DREAM to study pain. N. Engl. J. Med. 347:2002;362-364.
30. Volk H., Asadullah K., Gallagher G., Sabat R., Grutz G. IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets. Trends Immunol. 22:2001;414-417.
31. Watkins L.R., Maier S.F. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu. Rev. Psychol. 51:2000;29-57.
32. Woolfe G., McDonald A.D. The evaluation of the analgesic action of pethidine hydrochloride. J. Pharmacol. Exp. Ther. 80:1944;300-307.